Euclidean Capital LLC 13F holdings
Euclidean Capital LLC reported 10 positions with a total reported value of $439.8M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: VANGUARD INTL EQUITY INDEX F (61.8%), VANGUARD INDEX FDS (25.8%), ISHARES TR (4.2%), ORIC ORIC PHARMACEUTICALS INC (2.4%), TMS TEAMSHARES INC (2.1%). Against 2026-03-31 it opened 1 new position and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Euclidean Capital LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
10 largest of 10 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F | 3,243,484 | $271.6M | 61.8% |
| VANGUARD INDEX FDS | 520,000 | $113.3M | 25.8% |
| ISHARES TR | 369,600 | $18.3M | 4.2% |
| ORIC ORIC PHARMACEUTICALS INC | 989,410 | $10.7M | 2.4% |
| TMS TEAMSHARES INC | 1,099,974 | $9.0M | 2.1% |
| FHTX FOGHORN THERAPEUTICS INC | 1,573,761 | $7.7M | 1.7% |
| PMVP PMV PHARMACEUTICALS INC | 2,627,643 | $3.5M | 0.8% |
| ALEC ALECTOR INC | 1,307,858 | $2.6M | 0.6% |
| SRZN SURROZEN INC | 258,529 | $2.3M | 0.5% |
| TNYA TENAYA THERAPEUTICS INC | 1,015,705 | $750.7K | 0.2% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| TMS TEAMSHARES INC | 1,099,974 | $9.0M | 2.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
No position was decreased.
CIK 1825034 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
